nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabumetone—PTGS2—amyotrophic lateral sclerosis	0.517	1	CbGaD
Nabumetone—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.34	1	CbGbCtD
Nabumetone—Alveolitis allergic—Riluzole—amyotrophic lateral sclerosis	0.0118	0.0822	CcSEcCtD
Nabumetone—Gastric ulcer—Riluzole—amyotrophic lateral sclerosis	0.00529	0.0369	CcSEcCtD
Nabumetone—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.00469	0.0327	CcSEcCtD
Nabumetone—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.00435	0.0303	CcSEcCtD
Nabumetone—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.00383	0.0267	CcSEcCtD
Nabumetone—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.00334	0.0233	CcSEcCtD
Nabumetone—Melaena—Riluzole—amyotrophic lateral sclerosis	0.003	0.021	CcSEcCtD
Nabumetone—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.00289	0.0201	CcSEcCtD
Nabumetone—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00254	0.0177	CcSEcCtD
Nabumetone—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00238	0.0166	CcSEcCtD
Nabumetone—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00231	0.0161	CcSEcCtD
Nabumetone—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00223	0.0156	CcSEcCtD
Nabumetone—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00206	0.0144	CcSEcCtD
Nabumetone—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00203	0.0142	CcSEcCtD
Nabumetone—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00198	0.0138	CcSEcCtD
Nabumetone—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00193	0.0135	CcSEcCtD
Nabumetone—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00193	0.0135	CcSEcCtD
Nabumetone—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00189	0.0132	CcSEcCtD
Nabumetone—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00188	0.0131	CcSEcCtD
Nabumetone—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.0018	0.0126	CcSEcCtD
Nabumetone—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00178	0.0124	CcSEcCtD
Nabumetone—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00176	0.0123	CcSEcCtD
Nabumetone—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00176	0.0123	CcSEcCtD
Nabumetone—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00175	0.0122	CcSEcCtD
Nabumetone—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00173	0.0121	CcSEcCtD
Nabumetone—Depression—Riluzole—amyotrophic lateral sclerosis	0.00172	0.012	CcSEcCtD
Nabumetone—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.0017	0.0118	CcSEcCtD
Nabumetone—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00169	0.0118	CcSEcCtD
Nabumetone—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00168	0.0117	CcSEcCtD
Nabumetone—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00168	0.0117	CcSEcCtD
Nabumetone—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00164	0.0114	CcSEcCtD
Nabumetone—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00161	0.0112	CcSEcCtD
Nabumetone—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00155	0.0108	CcSEcCtD
Nabumetone—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00154	0.0108	CcSEcCtD
Nabumetone—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00146	0.0102	CcSEcCtD
Nabumetone—Chills—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00967	CcSEcCtD
Nabumetone—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00962	CcSEcCtD
Nabumetone—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00952	CcSEcCtD
Nabumetone—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00924	CcSEcCtD
Nabumetone—Tension—Riluzole—amyotrophic lateral sclerosis	0.00132	0.0092	CcSEcCtD
Nabumetone—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00911	CcSEcCtD
Nabumetone—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00879	CcSEcCtD
Nabumetone—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00125	0.0087	CcSEcCtD
Nabumetone—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00867	CcSEcCtD
Nabumetone—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00862	CcSEcCtD
Nabumetone—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00857	CcSEcCtD
Nabumetone—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00846	CcSEcCtD
Nabumetone—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00843	CcSEcCtD
Nabumetone—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00841	CcSEcCtD
Nabumetone—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.0012	0.0084	CcSEcCtD
Nabumetone—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00829	CcSEcCtD
Nabumetone—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00824	CcSEcCtD
Nabumetone—Cough—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00818	CcSEcCtD
Nabumetone—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00116	0.0081	CcSEcCtD
Nabumetone—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00114	0.00796	CcSEcCtD
Nabumetone—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00789	CcSEcCtD
Nabumetone—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00781	CcSEcCtD
Nabumetone—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00772	CcSEcCtD
Nabumetone—Oedema—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00765	CcSEcCtD
Nabumetone—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00765	CcSEcCtD
Nabumetone—Shock—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00753	CcSEcCtD
Nabumetone—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00749	CcSEcCtD
Nabumetone—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00106	0.0074	CcSEcCtD
Nabumetone—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00105	0.0073	CcSEcCtD
Nabumetone—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000992	0.00692	CcSEcCtD
Nabumetone—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000985	0.00687	CcSEcCtD
Nabumetone—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000978	0.00682	CcSEcCtD
Nabumetone—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000975	0.0068	CcSEcCtD
Nabumetone—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000966	0.00674	CcSEcCtD
Nabumetone—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000954	0.00665	CcSEcCtD
Nabumetone—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000946	0.0066	CcSEcCtD
Nabumetone—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000938	0.00655	CcSEcCtD
Nabumetone—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000904	0.00631	CcSEcCtD
Nabumetone—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000897	0.00626	CcSEcCtD
Nabumetone—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000872	0.00608	CcSEcCtD
Nabumetone—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000867	0.00605	CcSEcCtD
Nabumetone—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000867	0.00605	CcSEcCtD
Nabumetone—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000808	0.00564	CcSEcCtD
Nabumetone—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000787	0.00549	CcSEcCtD
Nabumetone—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000776	0.00542	CcSEcCtD
Nabumetone—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000751	0.00524	CcSEcCtD
Nabumetone—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000726	0.00506	CcSEcCtD
Nabumetone—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000698	0.00487	CcSEcCtD
Nabumetone—Rash—Riluzole—amyotrophic lateral sclerosis	0.000692	0.00483	CcSEcCtD
Nabumetone—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000691	0.00482	CcSEcCtD
Nabumetone—Headache—Riluzole—amyotrophic lateral sclerosis	0.000687	0.0048	CcSEcCtD
Nabumetone—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000652	0.00455	CcSEcCtD
